The  Cancer Biomarker Market Growth was estimated to be USD 11.1 billion in 2022. It is projected to reach USD 27.4 billion by 2030, with a compound annual growth rate (CAGR) of 12.0% during the forecast period from 2023 to 2030. The Cancer Biomarker Market, which refers to the market for identifying and measuring biomarkers that indicate the presence or progression of cancer, is...